Efficacy and Safety of Sevelamer Carbonate in Chinese Nondialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized, Double-Blind, Parallel-Group Study

• Main Authors: Wei Chen (Author), Hua-Feng Liu (Author), Qin-Kai Chen (Author), Ming-Hui Zhao (Author), Xiao-Nong Chen (Author), Hong Liu (Author), Jian-Xin Wan (Author), Shao-Mei Li (Author), Meng-Hua Chen (Author), Chun Dai (Author), Hong-Bin Shi (Author), Jia-Li Wei (Author), Hong-Wen Zhao (Author), Li-Hua Wang (Author), Gang Long (Author), Wan-Hong Lu (Author), Ying Tang (Author), Jun-Wei Yang (Author), Li-Ying Cao (Author), Dong-Xing Tang (Author), Yu-Qiong Yang (Author), Xue-Qing Yu (Author)
• Format: Book
• Published: Karger Publishers, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Previous studies suggested that sevelamer carbonate is well tolerated with a favorable efficacy and safety profile in both dialysis and nondialysis patients in Europe; however, the efficacy remains controversial, and few studies have examined sevelamer carbonate therapy in other ethnic...